Sawczuk I - Search Results

1

Role of carbonic anhydrases in the progression of renal cell carcinoma subtypes: proposal of a unified hypothesis.

Dorai T, Sawczuk I, Pastorek J, Wiernik PH, Dutcher JP. Dorai T, et al. Among authors: sawczuk i. Cancer Invest. 2006 Dec;24(8):754-79. doi: 10.1080/07357900601062321. Cancer Invest. 2006. PMID: 17162558 Review.

2

The role of carbonic anhydrase IX overexpression in kidney cancer.

Dorai T, Sawczuk IS, Pastorek J, Wiernik PH, Dutcher JP. Dorai T, et al. Eur J Cancer. 2005 Dec;41(18):2935-47. doi: 10.1016/j.ejca.2005.09.011. Eur J Cancer. 2005. PMID: 16310354

3

Apoptosis and expression of Bcl-2, Bcl-XL, and Bax in renal cell carcinomas.

Gobé G, Rubin M, Williams G, Sawczuk I, Buttyan R. Gobé G, et al. Among authors: sawczuk i. Cancer Invest. 2002;20(3):324-32. doi: 10.1081/cnv-120001177. Cancer Invest. 2002. PMID: 12025227

4

The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9.

McKiernan JM, Buttyan R, Bander NH, de la Taille A, Stifelman MD, Emanuel ER, Bagiella E, Rubin MA, Katz AE, Olsson CA, Sawczuk IS. McKiernan JM, et al. Among authors: sawczuk is. Cancer. 1999 Aug 1;86(3):492-7. doi: 10.1002/(sici)1097-0142(19990801)86:3<492::aid-cncr18>3.0.co;2-r. Cancer. 1999. PMID: 10430258

5

Expression of the tumor-associated gene MN: a potential biomarker for human renal cell carcinoma.

McKiernan JM, Buttyan R, Bander NH, Stifelman MD, Katz AE, Chen MW, Olsson CA, Sawczuk IS. McKiernan JM, et al. Among authors: sawczuk is. Cancer Res. 1997 Jun 15;57(12):2362-5. Cancer Res. 1997. PMID: 9192809

6

Detection of carbonic anhydrase-9 gene expression in peripheral blood cells predicts risk of disease recurrence in patients with renal cortical tumors.

Gilbert SM, Whitson JM, Mansukhani M, Buttyan R, Benson MC, Olsson CA, Sawczuk IS, McKiernan JM. Gilbert SM, et al. Urology. 2006 May;67(5):942-5. doi: 10.1016/j.urology.2005.11.034. Urology. 2006. PMID: 16698354

7

Radiologic follow-up of patients with T1-3a,b,c or T4N+M0 renal cell carcinoma after radical nephrectomy.

Saidi JA, Newhouse JH, Sawczuk IS. Saidi JA, et al. Among authors: sawczuk is. Urology. 1998 Dec;52(6):1000-3. doi: 10.1016/s0090-4295(98)00423-3. Urology. 1998. PMID: 9836544 Free article. Clinical Trial.

8

Renal cell carcinoma: should radical nephrectomy be performed in the presence of metastatic disease?

Sawczuk IS, Pollard JC. Sawczuk IS, et al. Curr Opin Urol. 1999 Sep;9(5):377-81. doi: 10.1097/00042307-199909000-00002. Curr Opin Urol. 1999. PMID: 10579074

9

Blood-based RT-PCR assays of MN/CA9 or PSMA: clinical application in renal cancer patients.

de la Taille A, Katz A, Cao Y, McKiernan J, Buttyan R, Burchardt M, Burchardt T, Hayek O, Olsson CA, Chopin DK, Sawczuk IS. de la Taille A, et al. Among authors: sawczuk is. Urology. 2000 Sep 1;56(3):393-8. doi: 10.1016/s0090-4295(00)00647-6. Urology. 2000. PMID: 10962301

10

Autolymphocyte therapy in the treatment of metastatic renal cell carcinoma.

Sawczuk IS. Sawczuk IS. Urol Clin North Am. 1993 May;20(2):297-301. Urol Clin North Am. 1993. PMID: 8493751 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page